|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Studies
on apoptosis of spermatogenic cells in normal fertile men treated with
supraphysiological doses of testosterone undecanoate
Yi-Feng
GE1, Yu-Feng HUANG1, Gui-Yuan ZHANG2,
Xing-Hai WANG3, Jian-Ping XU1
1Laboratory
of Reproduction and Genetics, General Hospital of Nanjing Command, PLA,
Nanjing 210002, China Asian J Androl 1999 Sep; 1: 155-158 Keywords:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Concentrations
(1109/L) |
Spermatogenic
cell/ |
|
| sperm |
spermatogenic
cell |
||
| Pretreatment |
49.930.3 |
1.341.94 |
0.027 |
| Day
30 |
17.422.1c |
0.810.60c |
0.046 |
| Day
60 |
8.714.5c |
0.700.98c |
0.081 |
| Day
90 |
1.13.0c |
0.240.33c |
0.226 |
The
apoptotic ratio, the ratio of the number of a particular type of apoptotic
spermatogenic cell to the total number of that type of cell, is an expression
of the degree or rate of apoptosis.
It
can be seen from Table 2 that the apoptotic ratios of spermatocyte and
spermatid were significantly increased on Day 30 as compared with the
pretreatment level (P<0.01); The ratios on Day 60 and 90 were
further increased to values significantly higher than those on Day 30
(P<0.01). Data indicated a gradual enhancement of apoptosis
in the course of TU administration. Apoptosis was found to be augmented
in the whole series of castoff spermatogenic cells, however, spermatogonia
were too few to be accurately counted.
Table
2. Effects of TU on apoptotic ratios of spermatogenic cells. means.
cP<0.01, compared with the pretreatment levels (Rank
sum and Dunnett t tests). fP<0.01, compared with
the Day 30 values (Rank sum and SNK tests).
|
|
n |
Apoptotic
ratio (%) |
|||
|
Spermatocytes |
Spermatids |
||||
|
WG
stain |
TUNEL |
WG
stain |
TUNEL |
||
|
Pretreatment |
20 |
1.40.9 |
4.31.8 |
1.70.8 |
4.32.6 |
|
Day
30 |
20 |
8.91.5c |
12.71.6c |
8.11.8c |
9.61.9c |
|
Day
60 |
16 |
7.82.2cf |
12.91.8cf |
8.02.1cf |
12.03.4cf |
|
Day
90 |
12 |
8.52.0cf |
13.31.6cf |
6.42.8cf |
12.51.8cf |
4 Discussion
Recent
experimental studies indicated that exogenous interference in spermatogenesis,
no matter accomplished by whatever means, such as FSH neutralizatiion[9], LH
deprivation[10], GnRH antagonists[11], or selective
intoxication of Leydig cells[12], may induce apoptosis in different
stages of spermatogenic cells. Only in case of Leydig cell intoxication,
was apoptosis enhanced in all stages of spermatogenic cells.
The
present paper showed that after TU treatment, the apoptotic spermatogenic
cells in the semen were gradually increased, indicating a progressive
enhancement of apoptosis in the course of treatment. Furthermore, apoptosis
was found to be augmented in the whole series of castoff spermatogenic
cells, an occurrence that bears
a similarity with the effect of Leydig cell intoxication. It is well known
that large doses of exogenous T suppresses endogenous T secretion through
a negative feed back mechanism with a resultant deprivation of the intratesticular
T, while in Leydig cell intoxication, the T production is arrested and
the intratesticular T is deprived. It can be seen that the two measures
reach the same consequence of intratesticular T deprivation. However,
supraphysiological doses of TU suppress GnRH, LH and FSH secretion as
well, which may also contribute to the enhancement
of apoptosis.
The
ratio of castoff spermatogenic cells to spermatozoa was increased gradually
from the pretreatment value of 0.027 up to 0.226 on Day 90. It may imply
a gradual exacerbation of spermatogenic arrest with a relative enhancement
of spermatogenic cells exfoliation and/or a decreased spermatozoa formation.
References
[1]
Ge YF, Huang YF. Apoptosis
of male germ cells. J Clin Lab Sci (China)
1998; 16: 254-6.
[2] Trauth BC, Keesey J. Cell death. In: Trauth BC, Keesey J, editors.
Guide to cell proliferation
and apoptosis methods. Indianapolis: Boehringer Mannheim; 1998. p 34-61.
[3] World Health Organization Task Force on Methods for the Regulation
of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia
and oligospermia in normal men. Fertil Steril 1996; 65: 821-9.
[4] Chen ZD, Cai SL, Chen YZ. Clinical observation on the antipermatogenic
effect of testosterone undecanoate. J Clin Androl (China) 1986; 1: 18-21.
[5] Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ. A pharmacokinetic study
of injectable testosterone undecanoate in hypogonadal men. J Androl 1998;
19: 761-8.
[6] Partsch C-J, Weinbauer GF, Fang TY, Nieschlag E. Injectable testosterone
undecanoate has more favourable pharmacokinetics and pharmacodynamics
than testosterone enanthate. Eur J Endocr 1995; 132: 514-9.
[7] Huang YF, Xu JP, Ge YF. Inspection of apoptotic spermatogenic cells.
Acta Anat Sin (China) 1996; 27: 59.
[8] Huang YF. A collection
of illustration plates of germ cells (China). Nanjing: Southeast University
Publisher; 1994. 29-100.
[9] Shetty J, Marathe GK, Dighe RR. Specific immunoneutralization of FSH
leads to apoptotic cell death of the pachytene spermatocytes and spermatogonial
cells in the rat. Endocrinology1996; 137: 2179-82.
[10] Marathe GK, Shetty
J, Dighe RR. Selective immunoneutralization of LH results in the apoptotic
cell death of pachytene spermatocytes and spermatids in the rat testis.
Endocrine 1995; 3: 705-9.
[11] Hikim AP, Wang C, Leung A, Swerdloff RS. Involvement of apoptosis
in the induction of germ cell degeneration in adult rats after gonadotropin-releasing
hormone antagonist treatment. Endocrinology 1995; 136: 2770-5.
[12] Kenth H, Harri H, Martti P. Testosterone inhibits and induces apoptosis
in rat seminiferous tubules in a stage-specific manner: in situ quantification
in squash preparations after adminstration of ethane dimethane sulfonate.
Endocrinology
1995; 136:3285-92.
Correspondence
to Dr. Yi-Feng GE.
Tel: +81-25-482 6808 Fax: +81-25-480 3061
Received
1999-04-16 Accepted 1999-09-16
